BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jafarzadeh A, Nemati M, Jafarzadeh S. Contribution of STAT3 to the pathogenesis of COVID-19. Microb Pathog 2021;154:104836. [PMID: 33691172 DOI: 10.1016/j.micpath.2021.104836] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 23.0] [Reference Citation Analysis]
Number Citing Articles
1 Zeng F, Xu Y, Tang C, Yan Z, Wei C. Integrated bioinformatics and in silico approaches reveal the biological targets and molecular mechanisms of 1,25-dihydroxyvitamin D against COVID-19 and diabetes mellitus. Front Nutr 2022;9. [DOI: 10.3389/fnut.2022.1060095] [Reference Citation Analysis]
2 Al‐kuraishy HM, Al‐gareeb AI, Mohammed AA, Alexiou A, Papadakis M, Batiha GE. The potential link between Covid‐19 and multiple myeloma: A new saga. Immunity Inflam & Disease 2022;10. [DOI: 10.1002/iid3.701] [Reference Citation Analysis]
3 Cavalcante LTDF, da Fonseca GC, Amado Leon LA, Salvio AL, Brustolini OJ, Gerber AL, Guimarães APDC, Marques CAB, Fernandes RA, Ramos Filho CHF, Kader RL, Pimentel Amaro M, da Costa Gonçalves JP, Vieira Alves-leon S, Vasconcelos ATR. Buffy Coat Transcriptomic Analysis Reveals Alterations in Host Cell Protein Synthesis and Cell Cycle in Severe COVID-19 Patients. IJMS 2022;23:13588. [DOI: 10.3390/ijms232113588] [Reference Citation Analysis]
4 Babalghith AO, Al-Kuraishy HM, Al-Gareeb AI, De Waard M, Al-Hamash SM, Jean-Marc S, Negm WA, Batiha GE. The role of berberine in Covid-19: potential adjunct therapy. Inflammopharmacology 2022. [PMID: 36183284 DOI: 10.1007/s10787-022-01080-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Al-Kuraishy HM, Al-Gareeb AI, Al-Maiahy TJ, Alexiou A, Mukerjee N, Batiha GE. Prostaglandins and non-steroidal anti-inflammatory drugs in Covid-19. Biotechnol Genet Eng Rev 2022;:1-21. [PMID: 36098621 DOI: 10.1080/02648725.2022.2122290] [Reference Citation Analysis]
6 Ostrycharz E, Hukowska-Szematowicz B. Micro-Players of Great Significance-Host microRNA Signature in Viral Infections in Humans and Animals. Int J Mol Sci 2022;23:10536. [PMID: 36142450 DOI: 10.3390/ijms231810536] [Reference Citation Analysis]
7 Lin X, Nie H, Tang R, Wang P, Jin X, Jiang Q, Han F, Chen N, Li Y. Network analysis between neuron dysfunction and neuroimmune response based on neural single-cell transcriptome of COVID-19 patients. Comput Biol Med 2022;150:106055. [PMID: 36137317 DOI: 10.1016/j.compbiomed.2022.106055] [Reference Citation Analysis]
8 Al-Kuraishy HM, Al-Gareeb AI, Negm WA, Alexiou A, Batiha GE. Ursolic acid and SARS-CoV-2 infection: a new horizon and perspective. Inflammopharmacology 2022. [PMID: 35922738 DOI: 10.1007/s10787-022-01038-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Phillips S, Khadka S, Bohan D, Espada CE, Maury W, Wu L. Epitranscriptomic N6-methyladenosine profile of SARS-CoV-2-infected human lung epithelial cells.. [DOI: 10.1101/2022.08.01.502311] [Reference Citation Analysis]
10 Sharif-zak M, Abbasi-jorjandi M, Asadikaram G, Ghoreshi Z, Rezazadeh-jabalbarzi M, Rashidinejad H. Influence of Disease Severity and Gender on HLA-C Methylation in COVID-19 Patients. Iran J Sci Technol Trans Sci 2022. [DOI: 10.1007/s40995-022-01334-1] [Reference Citation Analysis]
11 Saik OV, Klimontov VV. Gene Networks of Hyperglycemia, Diabetic Complications, and Human Proteins Targeted by SARS-CoV-2: What Is the Molecular Basis for Comorbidity? IJMS 2022;23:7247. [DOI: 10.3390/ijms23137247] [Reference Citation Analysis]
12 Nicoletti AS, Visacri MB, da Ronda CRDSC, Vasconcelos PEDNS, Quintanilha JCF, de Souza RN, Ventura DS, Eguti A, Silva LFS, Perroud Junior MW, Catharino RR, Reis LO, Dos Santos LA, Durán N, Fávaro WJ, Lancellotti M, da Costa JL, Moriel P, Pincinato EC. Differentially expressed plasmatic microRNAs in Brazilian patients with Coronavirus disease 2019 (COVID-19): preliminary results. Mol Biol Rep 2022. [PMID: 35301654 DOI: 10.1007/s11033-022-07338-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
13 Alfaro E, Díaz-garcía E, García-tovar S, Zamarrón E, Mangas A, Galera R, López-collazo E, García-rio F, Cubillos-zapata C. Upregulated Proteasome Subunits in COVID-19 Patients: A Link with Hypoxemia, Lymphopenia and Inflammation. Biomolecules 2022;12:442. [DOI: 10.3390/biom12030442] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Sharif-zak M, Abbasi-jorjandi M, Asadikaram G, Ghoreshi Z, Rezazadeh-jabalbarzi M, afsharipur A, Rashidinejad H, Khajepour F, Jafarzadeh A, Arefinia N, Kheyrkhah A, Abolhassani M. CCR2 and DPP9 expression in the peripheral blood of COVID-19 patients: Influences of the disease severity and gender. Immunobiology 2022;227:152184. [DOI: 10.1016/j.imbio.2022.152184] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
15 Beheshtirouy S, Khani E, Khiali S, Entezari-Maleki T. Investigational antiviral drugs for the treatment of COVID-19 patients. Arch Virol 2022. [PMID: 35138438 DOI: 10.1007/s00705-022-05368-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Vastrad B, Vastrad C. Comprehensive analysis of next-generation sequencing data in COVID-19 and its secondary complications.. [DOI: 10.1101/2022.02.03.478930] [Reference Citation Analysis]
17 Zalpoor H, Akbari A, Samei A, Forghaniesfidvajani R, Kamali M, Afzalnia A, Manshouri S, Heidari F, Pornour M, Khoshmirsafa M, Aazami H, Seif F. The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies. Cell Mol Biol Lett 2022;27:10. [PMID: 35109786 DOI: 10.1186/s11658-022-00311-1] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 26.0] [Reference Citation Analysis]
18 Bosch-Barrera J, Roqué A, Teixidor E, Carmona-Garcia MC, Arbusà A, Brunet J, Martin-Castillo B, Cuyàs E, Verdura S, Menendez JA. Clinical Management of COVID-19 in Cancer Patients with the STAT3 Inhibitor Silibinin. Pharmaceuticals (Basel) 2021;15:19. [PMID: 35056076 DOI: 10.3390/ph15010019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Emadi-Baygi M, Ehsanifard M, Afrashtehpour N, Norouzi M, Joz-Abbasalian Z. Corona Virus Disease 2019 (COVID-19) as a System-Level Infectious Disease With Distinct Sex Disparities. Front Immunol 2021;12:778913. [PMID: 34912345 DOI: 10.3389/fimmu.2021.778913] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Bess A, Berglind F, Mukhopadhyay S, Brylinski M, Griggs N, Cho T, Galliano C, Wasan KM. Artificial intelligence for the discovery of novel antimicrobial agents for emerging infectious diseases. Drug Discov Today 2021:S1359-6446(21)00478-5. [PMID: 34748992 DOI: 10.1016/j.drudis.2021.10.022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
21 Kgatle MM, Lawal IO, Mashabela G, Boshomane TMG, Koatale PC, Mahasha PW, Ndlovu H, Vorster M, Rodrigues HG, Zeevaart JR, Gordon S, Moura-Alves P, Sathekge MM. COVID-19 Is a Multi-Organ Aggressor: Epigenetic and Clinical Marks. Front Immunol 2021;12:752380. [PMID: 34691068 DOI: 10.3389/fimmu.2021.752380] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
22 Kircheis R. Coagulopathies after Vaccination against SARS-CoV-2 May Be Derived from a Combined Effect of SARS-CoV-2 Spike Protein and Adenovirus Vector-Triggered Signaling Pathways. Int J Mol Sci 2021;22:10791. [PMID: 34639132 DOI: 10.3390/ijms221910791] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
23 Jafarzadeh A, Naseri A, Shojaie L, Nemati M, Jafarzadeh S, Bannazadeh Baghi H, Hamblin MR, Akhlagh SA, Mirzaei H. MicroRNA-155 and antiviral immune responses. Int Immunopharmacol 2021;101:108188. [PMID: 34626873 DOI: 10.1016/j.intimp.2021.108188] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Jafarzadeh A, Jafarzadeh S, Nemati M. Therapeutic potential of ginger against COVID-19: Is there enough evidence? Journal of Traditional Chinese Medical Sciences 2021;8:267-79. [DOI: 10.1016/j.jtcms.2021.10.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 11.0] [Reference Citation Analysis]
25 Dhall A, Patiyal S, Sharma N, Devi NL, Raghava GPS. Computer-aided prediction of inhibitors against STAT3 for managing COVID-19 associated cytokine storm. Comput Biol Med 2021;137:104780. [PMID: 34450382 DOI: 10.1016/j.compbiomed.2021.104780] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]